Anticancer Peptides
Explore peptide research and guides on anticancer peptides.
Anticancer Peptides: How They Kill Tumor Cells
Anticancer peptides selectively destroy cancer cells through membrane disruption, apoptosis induction, and intracellular targeting. Here is what research shows.
Anticancer PeptidesAmphipathic Peptides vs Cancer Cell Membranes
Cancer cells have negatively charged membranes that amphipathic peptides exploit to selectively kill tumors. Here is what 9 studies reveal about this mechanism.
Anticancer PeptidesPeptides Targeting p53-MDM2: Reactivating p53 in Cancer
Peptide inhibitors of the p53-MDM2 interaction restore tumor suppression in wild-type p53 cancers. Here's how they work and where they stand clinically.
Anticancer PeptidesPro-Apoptotic Peptides: Triggering Cancer Cell Death
Pro-apoptotic peptides force cancer cells to self-destruct by targeting Bcl-2 survival proteins and disrupting mitochondria. Here is what the research shows.
Anticancer PeptidesStapled Peptides in Cancer: Alpha-Helix Drugs
Stapled peptides lock alpha-helical shapes to enter cells and disrupt p53-MDM2 interactions. ALRN-6924 reached Phase 1. Here's what the science shows.